JP2006513209A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513209A5
JP2006513209A5 JP2004563632A JP2004563632A JP2006513209A5 JP 2006513209 A5 JP2006513209 A5 JP 2006513209A5 JP 2004563632 A JP2004563632 A JP 2004563632A JP 2004563632 A JP2004563632 A JP 2004563632A JP 2006513209 A5 JP2006513209 A5 JP 2006513209A5
Authority
JP
Japan
Prior art keywords
oxo
pharmaceutical composition
compound
compound according
croh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004563632A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006513209A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/040104 external-priority patent/WO2004058246A1/en
Publication of JP2006513209A publication Critical patent/JP2006513209A/ja
Publication of JP2006513209A5 publication Critical patent/JP2006513209A5/ja
Pending legal-status Critical Current

Links

JP2004563632A 2002-12-17 2003-12-16 免疫調節因子および抗癌剤としてのトリプトライド誘導体 Pending JP2006513209A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43420302P 2002-12-17 2002-12-17
PCT/US2003/040104 WO2004058246A1 (en) 2002-12-17 2003-12-16 Triptolide derivatives as immunomodulator and anticancer agents

Publications (2)

Publication Number Publication Date
JP2006513209A JP2006513209A (ja) 2006-04-20
JP2006513209A5 true JP2006513209A5 (enExample) 2007-01-18

Family

ID=32682009

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004563632A Pending JP2006513209A (ja) 2002-12-17 2003-12-16 免疫調節因子および抗癌剤としてのトリプトライド誘導体

Country Status (7)

Country Link
US (2) US7019151B2 (enExample)
EP (1) EP1581208A1 (enExample)
JP (1) JP2006513209A (enExample)
CN (1) CN1726025A (enExample)
AU (1) AU2003297211A1 (enExample)
CA (1) CA2508217A1 (enExample)
WO (1) WO2004058246A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4680589B2 (ja) * 2002-05-31 2011-05-11 ファーマジェネシス, インコーポレイテッド アポトーシスおよび免疫抑制の調節のためのトリプトリド誘導体
US7820834B2 (en) * 2003-12-24 2010-10-26 Pharmagenesis, Inc. Triptolide 5,6-derivatives as immunomodulators and anticancer agents
CN1917893A (zh) * 2004-02-09 2007-02-21 美国泛华医药公司 从雷公藤多苷中分离雷公藤内酯醇化合物的方法
DK1732536T3 (da) * 2004-03-02 2012-06-25 Pharmagenesis Inc Tripolidlactonringderivater som immunomodulatorer og anticancermidler
WO2005115455A2 (en) * 2004-05-17 2005-12-08 Combinatorx, Incorporated Methods and reagents for the treatment of immunoinflammatory disorders
WO2006012204A2 (en) * 2004-06-25 2006-02-02 Pharmagenesis, Inc. Method for treatment of inflammatory disorders using triptolide compounds
US8617906B2 (en) 2004-10-13 2013-12-31 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
CN101352434B (zh) * 2007-07-25 2010-10-06 中山大学 雷公藤内酯醇在制备治疗与c-KIT酪氨酸激酶相关肿瘤的药物的用途
CN104387406A (zh) * 2009-02-05 2015-03-04 药物起源公司 作为抗癌药和免疫调制剂的雷公藤内酯 c-环衍生物
US9150600B2 (en) 2009-05-07 2015-10-06 Regents Of The University Of Minnesota Triptolide prodrugs
EP2427467B1 (en) 2009-05-07 2015-08-05 Regents of the University of Minnesota Triptolide prodrugs
CN102258525A (zh) * 2010-05-28 2011-11-30 上海汇伦生命科技有限公司 Hq-091212的药物应用
CN103709227B (zh) * 2012-10-09 2017-07-04 上海汇伦生命科技有限公司 双键取代雷公藤内酯衍生物及其制备方法和应用
CN105263475A (zh) * 2013-03-15 2016-01-20 制药创源有限公司 雷公藤甲素静脉注射乳剂用作免疫调制剂和抗癌药

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1027371C (zh) * 1989-09-08 1995-01-11 中国医学科学院皮肤病研究所 二萜内酯化合物的合成方法
US5430054A (en) * 1989-12-22 1995-07-04 Jiangsu Family Planning Institute Preparation methods of diterpene lactone compounds and application of the same to antifertility
US5663335A (en) * 1996-03-01 1997-09-02 Pharmagenesis, Inc. Immunosuppressive compounds and methods
CN1257507A (zh) * 1997-05-23 2000-06-21 赫斯特·马里昂·罗素公司 适合用于自身免疫性疾病治疗的新的雷公藤内酯衍生物
US6004999A (en) * 1997-05-23 1999-12-21 Hoechst Marion Roussel, Inc. Triptolide derivatives useful in the treatment of autoimmune diseases
DE69932649T2 (de) * 1998-09-02 2007-08-09 Pharmagenesis, Inc., Palo Alto Triptolid-Prodrugs mit hoher Wasserlöslichkeit
JP2001081030A (ja) * 1999-07-13 2001-03-27 Mitsuhiro Hatta 免疫抑制剤の副作用防御剤
US6620843B2 (en) * 2001-01-19 2003-09-16 Pharmagenesis Anticancer treatment using triptolide prodrugs

Similar Documents

Publication Publication Date Title
JP2004536811A5 (enExample)
JP2005053931A5 (enExample)
JP2007511546A5 (enExample)
JP2009538978A5 (enExample)
JP2009525302A5 (enExample)
JP2007538024A5 (enExample)
JP2009545527A5 (enExample)
JP2008520566A5 (enExample)
JP2010509386A5 (enExample)
JP2010501534A5 (enExample)
JP2007537301A5 (enExample)
JP2008517030A5 (enExample)
JP2007502817A5 (enExample)
JP2008513510A5 (enExample)
JP2008526897A5 (enExample)
JP2007537287A5 (enExample)
JP2011527678A5 (enExample)
JP2005536531A5 (enExample)
JP2003520208A5 (enExample)
JP2006518765A5 (enExample)
JP2006244739A5 (enExample)
JP2010510263A5 (enExample)
JP2006510659A5 (enExample)
JP2006527285A5 (enExample)
JP2008520709A5 (enExample)